BDH Industries logo

BDH Industries

BDHINDUSTRIESLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹297 Cr
Volatility
Moderate
P/E Ratio
25.4
EBITDA
₹16.10 Cr
Return on Equity
14.04%
Debt to Equity
0.03
Book Value
₹131.42
EPS
₹17.05
52W High
₹610
52W Low
₹306

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

3
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 27.0%

Weaknesses

1
  • The company has delivered a poor sales growth of 10.8% over past five years.

Growth Rate

Revenue Growth
43.78% higher than 3Y
Net Income Growth
16.13% higher than 3Y
Cash Flow Change
-116% lower than 3Y
ROE
4.08% lower than 3Y
ROCE
7.65% higher than 3Y
EBITDA Margin (Avg.)
-16.52% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
18.31
19.35
21.06
27.11
16.26
16.23
16.2
17.82
18.62
18.96
29.34
29.03
22.38
Expenses
16.35
16.18
17.57
23.3
14.3
13.18
12.67
14.75
16.5
15.63
25.11
24.82
18.92
Operating Profit
1.96
3.17
3.49
3.81
1.96
3.05
3.53
3.07
2.12
3.33
4.23
4.21
3.46
OPM %
10.7%
16.38%
16.57%
14.05%
12.05%
18.79%
21.79%
17.23%
11.39%
17.56%
14.42%
14.5%
15.46%
Other Income
0.37
0.41
0.37
0.43
0.38
0.43
0.46
0.57
0.55
0.55
0.53
0.61
0.45
Interest
0.04
0.03
0.02
0.1
0.02
0.04
0.01
0.01
0.01
0.03
0.01
0.01
0.01
Depreciation
0.13
0.13
0.13
0.18
0.22
0.23
0.23
0.23
0.22
0.22
0.22
0.22
0.21
PBT
2.16
3.42
3.71
3.96
2.1
3.21
3.75
3.4
2.44
3.63
4.53
4.59
3.69
Tax %
25%
26.61%
25.07%
25.25%
25.24%
25.23%
25.07%
26.76%
25%
27.82%
22.96%
37.25%
26.29%
Net Profit
1.62
2.51
2.78
2.96
1.57
2.41
2.81
2.49
1.83
2.62
3.49
2.88
2.72
EPS in Rs
2.81
4.36
4.83
5.14
2.73
4.19
4.88
4.32
3.18
4.55
6.06
5
4.72
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
44
46
43
41
52
59
57
69
74
86
67
96
100
Expenses
40
42
38
36
45
51
49
60
64
73
55
82
84
Operating Profit
4
4
5
5
7
9
9
9
11
12
12
14
15
OPM %
9%
9%
11%
13%
14%
15%
15%
13%
15%
14%
17%
14%
15%
Other Income
1
2
1
1
1
1
1
1
1
2
2
2
2
Interest
0
0
0
0
1
1
0
0
0
0
0
0
0
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
PBT
4
5
5
5
7
8
9
10
11
13
12
15
16
Tax %
32%
33%
33%
27%
26%
27%
27%
24%
26%
25%
26%
29%
—
Net Profit
3
3
3
4
5
6
6
7
8
10
9
11
12
EPS in Rs
4.46
5.61
5.8
6.53
8.39
10.32
11.05
12.54
14.24
17.14
16.1
18.78
20.33
Div. Payout %
39%
37%
36%
36%
34%
25%
28%
29%
28%
26%
28%
27%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6
6
6
6
6
6
6
6
6
6
6
6
Reserves
18
21
23
25
28
32
37
43
49
56
63
71
Borrowings
9
9
8
8
13
9
9
2
5
9
1
2
Other Liabilities
19
15
17
18
18
18
19
18
20
23
17
20
Total Liabilities
52
52
54
57
66
65
71
69
80
93
87
99
Fixed Assets
13
13
23
23
22
21
20
20
19
20
20
19
CWIP
0
4
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
38
35
31
34
44
44
51
49
61
73
67
80
Total Assets
52
52
54
57
66
65
71
69
80
93
87
99
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
6
4
7
0
-4
11
1
3
6
-2
15
-2
Investing
0
-5
-5
0
1
1
1
1
0
0
2
2
Financing
-3
-1
-3
-3
3
-6
-2
-8
0
1
-10
-2
Net Cash Flow
3
-1
-1
-2
0
6
0
-4
7
-1
6
-2
Free Cash Flow
6
0
1
-1
-4
11
1
4
6
-4
15
-2
CFO/OP
198
146
186
21
-24
153
35
64
82
11
153
8
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
81
64
67
63
89
68
96
76
82
121
78
120
Inventory Days
71
61
39
95
89
51
53
50
53
30
65
28
Days Payable
201
162
192
244
188
158
171
123
139
128
134
91
Cash Conversion Cycle
-49
-37
-85
-85
-10
-39
-21
4
-5
23
9
58
Working Capital Days
-76
-72
-90
-60
-29
-31
6
56
49
71
102
116
ROCE %
13%
15%
14%
14%
16%
19%
18%
18%
20%
21%
18%
20%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view BDH Industries insights

64 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

FIIs0.28%Promot.49.70%Others20.89%Public29.13%As ofJun 2026

Documents

1
Concall - Nov 2025 Nov 2025
2
Concall - Aug 2025 Aug 2025
3
Concall - Nov 2024 Nov 2024
4
Concall - May 2024 May 2024
5
Concall - Nov 2023 Nov 2023

Frequently Asked Questions about BDH Industries

What does BDH Industries Ltd do?
Incorporated in 1935, BDH Industries Ltd manufactures therapeutic formulations covering wide range of pharmaceuticals[1]
Where is BDH Industries Ltd (524828) listed?
BDH Industries Ltd trades as BDHINDUSTRIESLTD on the NSE and under code BDH on the BSE.
Which sector does BDH Industries Ltd belong to?
BDH Industries Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of BDH Industries Ltd?
BDH Industries Ltd has a market capitalisation of ₹296.9 Cr, which places it in the Small Cap band.
What is the PE ratio of BDH Industries Ltd?
BDH Industries Ltd trades at a PE ratio of 25.40, on earnings per share of ₹17.05, against a book value of ₹131.42 per share.
What is the 52-week high and low of BDH Industries Ltd?
Over the last 52 weeks BDH Industries Ltd has traded between ₹306 and ₹610.
Does BDH Industries Ltd pay dividends?
BDH Industries Ltd has a dividend yield of 0.97%.
What is the Return on Equity (ROE) of BDH Industries Ltd?
BDH Industries Ltd reported a return on equity of 14.04%. Its debt-to-equity ratio is 0.03.

Company Information

Incorporated in 1935, BDH Industries Ltd manufactures therapeutic formulations covering wide range of pharmaceuticals[1]

Website bdhind.com
Listed 1995-04-24
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524828.md for BDH Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List